Alzheimer’s Disease II

Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Wolfe, Michael S. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Σειρά:Topics in Medicinal Chemistry, 24
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03344nam a22005055i 4500
001 978-3-319-59460-6
003 DE-He213
005 20170515143859.0
007 cr nn 008mamaa
008 170515s2017 gw | s |||| 0|eng d
020 |a 9783319594606  |9 978-3-319-59460-6 
024 7 |a 10.1007/978-3-319-59460-6  |2 doi 
040 |d GrThAP 
050 4 |a RS400-431 
072 7 |a PSB  |2 bicssc 
072 7 |a SCI013020  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
245 1 0 |a Alzheimer’s Disease II  |h [electronic resource] /  |c edited by Michael S. Wolfe. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a VII, 202 p. 90 illus., 33 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Topics in Medicinal Chemistry,  |x 1862-2461 ;  |v 24 
505 0 |a Targets and Strategies Toward the Development of Alzheimer Therapeutics -- The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer’s Disease -- γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease -- Inhibitors of Tau-Phosphorylating Kinases -- Microtubule-Stabilizing Agents for Alzheimer’s and Other Tauopathies -- PET Imaging Agents for Alzheimer’s Disease. 
520 |a Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors . 
650 0 |a Chemistry. 
650 0 |a Neurosciences. 
650 0 |a Pharmaceutical technology. 
650 0 |a Medicinal chemistry. 
650 0 |a Proteins. 
650 1 4 |a Chemistry. 
650 2 4 |a Medicinal Chemistry. 
650 2 4 |a Pharmaceutical Sciences/Technology. 
650 2 4 |a Receptors. 
650 2 4 |a Neurosciences. 
700 1 |a Wolfe, Michael S.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319594590 
830 0 |a Topics in Medicinal Chemistry,  |x 1862-2461 ;  |v 24 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-59460-6  |z Full Text via HEAL-Link 
912 |a ZDB-2-CMS 
950 |a Chemistry and Materials Science (Springer-11644)